12 hrs ago
Scripps scientists win $2M research grant
The National Institutes of Health provided the five-year grant to a team led by Douglas Kojetin , an associate professor.
Scientists awarded $2 million to study improvements in anti-diabetic drug design
Scientists from the Florida campus of The Scripps Research Institute have been awarded $2.1 million from the National Institutes of Health to study the therapeutic potential of safer and more effective alternatives to the current crop of anti-diabetic drugs, which have been limited in their use due to side effects including bone loss and congestive ... (more)
Utilisation trends of rosiglitazone and pioglitazone in Australia before and after safety warnings
A series of drug safety warnings have recently been made by drug authorities relating to adverse effects of rosiglitazone and pioglitazone on cardiovascular diseases and bladder cancer.
Study: Heavy teens have trouble...
New research sends a stark warning to overweight teens: If you develop diabetes, you'll have a very tough time keeping it under control.
Rosiglitazone Causes Cardiotoxicity via Peroxisome...
To whom correspondence should be addressed at Department of Anesthesiology and Critical Care Medicine, Children's Hospital of Philadelphia and University of Pennsylvania, 3615 Civic Center Blvd, ARC 402G, Philadelphia, PA 19104.